Pralia subcutaneous injection 60mg syringe, manufactured by Daiichi Sankyo, contains denosumab (genetical recombination). This subcutaneous injection is indicated for the treatment of osteoporosis and for inhibiting bone erosion in rheumatoid arthritis. It is a 60mg 1mL 1 tube with YJ code 3999435G1023.
Pralia subcutaneous injection 60mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →